We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$19.8B
AUM Growth
+$142M
Cap. Flow
-$515M
Cap. Flow %
-2.6%
Top 10 Hldgs %
32.72%
Holding
349
New
12
Increased
106
Reduced
177
Closed
17

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$154M
2
ABBV icon
AbbVie
ABBV
+$153M
3
TEL icon
TE Connectivity
TEL
+$103M
4
JNJ icon
Johnson & Johnson
JNJ
+$52.1M
5
ACN icon
Accenture
ACN
+$50.8M

Top Sells

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$163M
2
TRV icon
Travelers Companies
TRV
+$135M
3
PEP icon
PepsiCo
PEP
+$117M
4
TXN icon
Texas Instruments
TXN
+$107M
5
MRK icon
Merck
MRK
+$104M

Sector Composition

Rank Sector Weight
1 Technology 23.93%
2 Financials 16.28%
3 Healthcare 14.28%
4 Industrials 11.17%
5 Consumer Staples 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRCX icon
276
Lam Research
LRCX
$390B
$545K ﹤0.01%
5,602
+102
+2% +$8.09K
CHRW icon
277
C.H. Robinson
CHRW
$17.5B
$544K ﹤0.01%
5,670
-60
-1% -$5.62K
SSD icon
278
Simpson Manufacturing
SSD
$8.16B
$525K ﹤0.01%
3,383
-166
-5% -$25.7K
POOL icon
279
Pool Corp
POOL
$7.5B
$523K ﹤0.01%
1,795
-320
-15% -$96.8K
DHR icon
280
Danaher
DHR
$144B
$519K ﹤0.01%
2,627
+17
+0.7% +$3.3K
MCK icon
281
McKesson
MCK
$101B
$518K ﹤0.01%
707
– –
NTRS icon
282
Northern Trust
NTRS
$33.9B
$507K ﹤0.01%
3,995
– –
HBAN icon
283
Huntington Bancshares
HBAN
$35.5B
$494K ﹤0.01%
29,450
-2,970
-9% -$44.8K
WST icon
284
West Pharmaceutical
WST
$24.9B
$465K ﹤0.01%
2,125
-200
-9% -$42.8K
CHKP icon
285
Check Point Software Technologies
CHKP
$13.1B
$465K ﹤0.01%
2,100
– –
VSS icon
286
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.9B
$458K ﹤0.01%
3,405
-130
-4% -$16K
EPD icon
287
Enterprise Products Partners
EPD
$81.7B
$457K ﹤0.01%
14,751
+400
+3% +$12.5K
BF.B icon
288
Brown-Forman Class B
BF.B
$13.1B
$449K ﹤0.01%
16,695
-1,450
-8% -$46.5K
SNV
289
DELISTED
Synovus
SNV
$446K ﹤0.01%
8,622
– –
VXUS icon
290
Vanguard Total International Stock ETF
VXUS
$160B
$437K ﹤0.01%
6,323
– –
BSX icon
291
Boston Scientific
BSX
$71.5B
$437K ﹤0.01%
4,064
– –
SPEM icon
292
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
$434K ﹤0.01%
10,160
+1,510
+17% +$60.9K
BNY
293
Bank of New York Mellon
BNY
$107B
$431K ﹤0.01%
4,727
+54
+1% +$4.59K
OGE icon
294
OGE Energy
OGE
$9.71B
$422K ﹤0.01%
9,500
– –
CI icon
295
Cigna
CI
$74.6B
$413K ﹤0.01%
1,248
– –
EW icon
296
Edwards Lifesciences
EW
$51.7B
$399K ﹤0.01%
5,098
– –
CNQ icon
297
Canadian Natural Resources
CNQ
$93.8B
$381K ﹤0.01%
12,138
-48
-0.4% -$1.45K
CAG icon
298
Conagra Brands
CAG
$7.23B
$366K ﹤0.01%
17,897
-252,085
-93% -$5.91M
C icon
299
Citigroup
C
$226B
$358K ﹤0.01%
4,203
+213
+5% +$15.4K
RGLD icon
300
Royal Gold
RGLD
$19.5B
$356K ﹤0.01%
2,000
– –
10 11
12
13 14

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q2 2025 Portfolio in Review

As of Q2 2025, Bahl & Gaynor held 349 positions worth $19.8B, up 0.72% from $19.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bahl & Gaynor's Q2 2025 filing shows 12 new, 106 increased, 177 reduced and 17 closed positions. Its largest new stake was AvalonBay Communities: 245,420 shares worth $49.9M. The largest sale was Williams Companies, an estimated $163M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q2 2025 buy was AvalonBay Communities: 245,420 shares worth $49.9M.
  • Bahl & Gaynor added most to UnitedHealth in Q2 2025, an estimated $154M increase.
  • Bahl & Gaynor's biggest Q2 2025 reduction was Williams Companies, cutting an estimated $163M.
  • Bahl & Gaynor fully exited United Parcel Service in Q2 2025, selling an estimated $13.9M.
  • Bahl & Gaynor's ten largest holdings make up 33% of its $19.8B portfolio in Q2 2025.
  • Bahl & Gaynor opened 12 new positions and closed 17 in Q2 2025.
  • Bahl & Gaynor's portfolio value rose 0.72% quarter-over-quarter to $19.8B.

Based on Bahl & Gaynor's 13F filing for Q2 2025, filed 12 Aug 2025.